WallStreetZenWallStreetZen

NASDAQ: STOK
Stoke Therapeutics Inc Stock Ownership - Who owns Stoke Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Stoke Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Edward M. Md KayeDirector2025-09-0345,996$20.13
$925.85kSell
Jonathan AllanGENERAL COUNSEL CORP SEC2025-09-036,345$20.07
$127.32kSell
Jonathan AllanGENERAL COUNSEL CORP SEC2025-09-029,150$7.07
$64.69kBuy
Barry TichoCHIEF MEDICAL OFFICER2025-09-025,501$19.87
$109.33kSell
Edward M. Md KayeDirector2025-09-0214,860$20.14
$299.27kSell
Jonathan AllanGENERAL COUNSEL CORP SEC2025-09-0214,922$20.14
$300.48kSell
Edward M. Md KayeDirector2025-08-291,029$20.00
$20.58kSell
Jonathan AllanGENERAL COUNSEL CORP SEC2025-08-29850$7.07
$6.01kBuy
Jonathan AllanGENERAL COUNSEL CORP SEC2025-08-29850$20.00
$17.00kSell
Jonathan AllanGENERAL COUNSEL CORP SEC2025-08-181,683$18.24
$30.69kSell

1 of 5

STOK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when STOK insiders and whales buy or sell their stock.

STOK Shareholders

What type of owners hold Stoke Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Seth Loring Harrison61.95%33,948,426$796.43MInsider
Apple Tree Partners IV LP31.32%17,161,713$402.61MInsider
Fmr LLC13.53%7,412,982$173.91MInstitution
Blackrock Inc10.81%5,924,567$138.99MInstitution
Lynx1 Capital Management LP9.86%5,404,674$126.79MInstitution
Rtw Investments LP9.35%5,123,525$120.20MInstitution
Baker Bros Advisors LP8.46%4,633,838$108.71MInstitution
Redmile Group LLC7.99%4,375,931$102.66MInstitution
Trust Skorpios7.13%3,906,181$91.64MInsider
Morgan Stanley6.52%3,573,976$83.85MInstitution

1 of 3

STOK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
STOK52.27%47.73%Net SellingNet Selling
NVAX62.75%17.11%Net Selling
PHVS82.28%0.00%
ABCL36.06%44.65%Net Buying
SNDX91.99%8.01%Net BuyingNet Selling
View Top Biotech Stocks

Stoke Therapeutics Stock Ownership FAQ

Who owns Stoke Therapeutics?

Stoke Therapeutics (NASDAQ: STOK) is owned by 119.62% institutional shareholders, 109.23% Stoke Therapeutics insiders, and 0.00% retail investors. Seth Loring Harrison is the largest individual Stoke Therapeutics shareholder, owning 33.95M shares representing 61.95% of the company. Seth Loring Harrison's Stoke Therapeutics shares are currently valued at $796.43M.

If you're new to stock investing, here's how to buy Stoke Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.